Immix Biopharma

Youtube Subscribe

Open: 6.82 Close: 6.06 Change: -0.76

The best way to get information about Immix Biopharma Company Inc Stock: Use an AI.

This document will help you to evaluate Immix Biopharma without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Immix Biopharma are: Immix, Biopharma, NASDAQIMMX, trading, defense, world, immix, …

Concept Map

Semantic Network

Stock Summary

Immix Biopharma, Inc. engages in developing tissue-specific therapeutics in oncology and inflammation. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft.

Today's Summary

Immix Biopharma (NASDAQ:IMMX) trading down 12.4% - defense world. immix biopharma. Director Jason Hsu bought 25,000 shares of the companys stock in a transaction dated Friday, December 8th. The firm has a market cap of $120.41 million, a P/E ratio of -6.59. Immix Biopharma, Inc. Completes 3rd NXC-201 Engineering Batch at its U.S. clinical trial. ImmixBio is a clinical-stage biopharmaceutical company pioneering personalized therapies.

Today's News

Immix Biopharma (NASDAQ:IMMX) trading down 12.4% - defense world. immix biopharma. Director Jason Hsu bought 25,000 shares of the companys stock in a transaction dated Friday, December 8th. The firm has a market cap of $120.41 million, a P/E ratio of -6.59. Immix Biopharma, Inc. Completes 3rd NXC-201 Engineering Batch at its U.S. clinical trial. ImmixBio is a clinical-stage biopharmaceutical company pioneering personalized therapies.

Stock Profile

"Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the treatment of ulcerative colitis and severe Crohn's disease. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. The company was incorporated in 2012 and is headquartered in Los Angeles, California."

Keywords

Are looking for the most relevant information about Immix Biopharma? Investor spend a lot of time searching for information to make investment decisions in Immix Biopharma. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Immix Biopharma are: Immix, Biopharma, NASDAQIMMX, trading, defense, world, immix, and the most common words in the summary are: therapeutic, pharmaceutical, inc, biopharma, pharma, bioscience, science, . One of the sentences in the summary was: Completes 3rd NXC-201 Engineering Batch at its U.S. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #pharmaceutical #inc #biopharma #pharma #bioscience #science.

Read more →

Youtube Subscribe

---